IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,733,186 | -6.3% | 126,393 | -15.3% | 0.17% | +2.4% |
Q2 2023 | $6,121,594 | +14.8% | 149,198 | -0.0% | 0.17% | +8.4% |
Q1 2023 | $5,334,088 | +107117.8% | 149,247 | +13.3% | 0.15% | -1.3% |
Q4 2022 | $4,975 | -99.9% | 131,711 | +6.7% | 0.16% | -11.9% |
Q3 2022 | $5,458,000 | +13.2% | 123,396 | -5.2% | 0.18% | +22.1% |
Q2 2022 | $4,821,000 | -0.1% | 130,224 | -0.1% | 0.14% | +27.2% |
Q1 2022 | $4,827,000 | +13.5% | 130,320 | -6.7% | 0.11% | +34.1% |
Q4 2021 | $4,252,000 | -6.6% | 139,721 | +2.9% | 0.08% | -9.6% |
Q3 2021 | $4,554,000 | -29.8% | 135,787 | -16.5% | 0.09% | -19.0% |
Q2 2021 | $6,483,000 | -16.3% | 162,528 | -5.7% | 0.12% | -19.4% |
Q1 2021 | $7,749,000 | -23.1% | 172,348 | -3.3% | 0.14% | -25.0% |
Q4 2020 | $10,081,000 | +19.8% | 178,304 | +0.6% | 0.19% | -13.9% |
Q3 2020 | $8,412,000 | -26.5% | 177,284 | -8.6% | 0.22% | -31.4% |
Q2 2020 | $11,440,000 | +8.8% | 194,030 | -12.7% | 0.32% | -13.8% |
Q1 2020 | $10,512,000 | -17.5% | 222,342 | +5.5% | 0.38% | +16.4% |
Q4 2019 | $12,737,000 | +9.4% | 210,843 | +8.5% | 0.32% | +2.2% |
Q3 2019 | $11,642,000 | -3.4% | 194,329 | +3.6% | 0.32% | +6.4% |
Q2 2019 | $12,055,000 | -21.5% | 187,561 | -0.8% | 0.30% | -22.4% |
Q1 2019 | $15,348,000 | +6.1% | 189,088 | -29.3% | 0.38% | -5.9% |
Q4 2018 | $14,461,000 | +4.1% | 267,492 | -0.7% | 0.41% | +24.0% |
Q3 2018 | $13,895,000 | +2.0% | 269,382 | -17.6% | 0.33% | -3.2% |
Q2 2018 | $13,616,000 | – | 326,765 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |